Zymeworks (ZYME) Operating Leases (2021 - 2026)

Zymeworks has reported Operating Leases for 6 years, with the latest figure at $13.8 million in Q1 2026.

• Quarterly Operating Leases fell 25.46% year-over-year to $13.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.8 million (down 25.46% YoY) and the FY2025 annual result came in at $14.8 million, down 20.17% from the prior year.
• Operating Leases retreated to $13.8 million in Q1 2026 per ZYME's latest filing, from $14.8 million in the prior quarter.
• Over five years, Operating Leases peaked at $30.1 million in Q3 2022 and troughed at $13.8 million in Q1 2026.
• A 5-year average of $21.6 million and a median of $20.0 million in 2024 frame the typical range for Operating Leases.
• The widest YoY moves for Operating Leases: up 5.87% in 2024, down 34.52% in 2024.
• Over 5 years, Operating Leases stood at $28.0 million in 2022, then dropped by 4.42% to $26.8 million in 2023, then sank by 30.72% to $18.5 million in 2024, then dropped by 20.17% to $14.8 million in 2025, then retreated by 6.98% to $13.8 million in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $13.8 million, $14.8 million, and $15.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.